Migration contributes to flat HBV infection prevalence rate in US

August 12, 2015

Migration contributes to flat HBV infection prevalence rate in U.S.
(HealthDay)—The prevalence of chronic hepatitis B virus (HBV) infection has remained constant since 1999, according to a study published online Aug. 6 in Hepatology.

Henry Roberts, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues sought to determine the prevalence of HBV among non-institutionalized individuals aged 6 years and older. They examined the prevalence of antibody to hepatitis B core antigen (anti-HBc), hepatitis B surface antigen, and antibody to B surface antigen over three periods: 1988 to 1994, 1999 to 2009, and 2007 to 2012.

The researchers found that for 2007 to 2012, 3.9 percent had anti-HBc. Since 1999, the overall prevalence of chronic HBV infection remained constant at 0.3 percent; the prevalence among non-Hispanic blacks was two- to three-fold greater than that seen in the general population. During 2011 to 2012, an estimated 3.1 percent of non-Hispanic Asians were chronically infected with HBV. Since 1999, there was a 16 percent increase in the adjusted prevalence of vaccine-induced immunity, and there was an increase in the number of persons, mainly young, with serologic evidence of vaccine protection from HBV infection, from 57.8 to 68.5 million.

"Despite increasing immune protection in young persons vaccinated in infancy, an analysis of B prevalence in racial and ethnic populations indicates that during 2011 to 2012 there were 847,000 HBV infections (which included ~400,000 non-Hispanic Asians) in the non-institutionalized U.S. population," the authors write.

Explore further: Risk of hepatitis D higher among HIV infected and injection drug users

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Risk of hepatitis D higher among HIV infected and injection drug users

April 21, 2015
Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country. ...

Global expansion of hepatitis vaccination needed to progress hepatitis B elimination

April 23, 2015
Results revealed today at The International Liver Congress 2015 demonstrate current treatment and prevention programmes need to be scaled up in order to make elimination of hepatitis B virus (HBV) possible.

Taking immunosuppressives, anti-cancer drugs may reactivate Hepatitis B

February 5, 2015
Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report from the Emerging Trends ...

Hepatitis B immunization program in Taiwan associated with reduction in chronic liver disease deaths

September 3, 2013
"Hepatitis B virus (HBV) infection causes infant fulminant hepatitis (IFH), and chronic HBV infection may progress to chronic liver disease (CLD) and hepatocellular carcinoma (HCC). Taiwan launched a nationwide HBV immunization ...

Drug prevents passage of HBV during pregnancy

June 1, 2015
The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the ...

Study quantifies prevalence of chronic HCV infection

March 4, 2014
(HealthDay)—The prevalence of hepatitis C virus (HCV) infection is about 1 percent, with 2.7 million U.S. residents estimated as having chronic HCV infection, according to a study published in the March 4 issue of the Annals ...

Recommended for you

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.